Transgenic mice over-expressing Nrf2 in astrocytes are resistant to MPTP neurotoxicity and when crossed into a transgenic mouse model of amyotrophic lateral sclerosis they delayed disease onset and prolonged survival [22], [23]. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.